Influenza Vaccination After Recent Influenza Infection in Children

Rationale for Vaccination After Recent Infection

• The American Academy of Pediatrics (AAP) recommends annual influenza vaccination for all children 6 months and older, regardless of prior influenza infection during the same season, to reduce morbidity and mortality associated with influenza 1, 2

Timing Considerations

• The child should be free from moderate to severe acute illness before receiving the vaccine, but minor illnesses are not contraindications to influenza vaccination 3, 4
• There is no required waiting period after influenza infection before administering the vaccine, only that the child has clinically recovered from the acute illness 3, 5

Vaccine Selection After Recent Infection

• Any age-appropriate influenza vaccine formulation can be used, including inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV) for healthy children 2 years and older without contraindications 1, 2, 4, 6, 7
• For children 6 months through 35 months, a 0.25 mL dose of IIV or age-appropriate dose of other formulations is recommended, while children 36 months and older should receive a 0.5 mL dose of any available, licensed, age-appropriate vaccine 2, 4, 6

Special Considerations

• Children who have never received influenza vaccine before or have only received one dose before July 1, 2021, should receive two doses 4 weeks apart, and those with high-risk conditions should be prioritized for vaccination even after recent infection 1, 4, 5
• Antiviral medication use within the previous 48 hours is a contraindication to LAIV but not to inactivated vaccines 3

Common Pitfalls to Avoid

• Delaying vaccination unnecessarily after recovery from influenza may leave the child vulnerable during peak influenza season 8

COVID-19 and Influenza Vaccination Recommendations for Young Children

Influenza Vaccination Recommendations

• The American Academy of Pediatrics (AAP) and Advisory Committee on Immunization Practices (ACIP) recommend annual influenza vaccination for all children 6 months of age and older 9, 10, 11
• Children 6 months through 8 years receiving influenza vaccine for the first time require 2 doses administered at least 4 weeks apart 11
• European health authorities recommend annual influenza vaccination for children 6 months and older, with special emphasis on children with underlying medical conditions 9
• Japan recommends annual influenza vaccination for children starting at 6 months of age 11

COVID-19 Vaccination Recommendations

• Neither European nor Japanese health authorities have implemented recommendations for annual COVID-19 boosters in 12-month-old children 12

Considerations for Vaccination in Young Children

• Children under 5 years, particularly those under 2 years, are at higher risk for influenza-related complications and hospitalizations 9, 13
• Influenza vaccination has been shown to reduce hospitalization rates in children by approximately 53.9% when fully vaccinated 13
• Up to 80% of influenza-associated pediatric deaths have occurred in unvaccinated children 6 months and older 13

Common Pitfalls to Avoid

• Delaying the second dose of influenza vaccine beyond the recommended interval may leave children inadequately protected during peak influenza season 14
• Failing to recognize that recommendations evolve as new evidence emerges and as the epidemiology of respiratory viruses changes 11

Influenza Vaccination Timing and Dosing

Key Recommendations

• The American Academy of Pediatrics recommends that children be free from moderate to severe acute illness before receiving the influenza vaccine, with minor illnesses not being a contraindication 15
• The American Academy of Pediatrics suggests that minor residual symptoms such as mild upper respiratory symptoms or allergic rhinitis do not preclude vaccination 16

Age-Specific Dosing

• For babies 6-35 months, any licensed, age-appropriate inactivated influenza vaccine can be used at the dose indicated for the specific vaccine product, with a 0.25 mL or 0.5 mL dose being appropriate depending on the formulation 15, 17
• For children 36 months and older, a 0.5 mL dose of any available, licensed, age-appropriate vaccine should be administered 15, 17

Two-Dose Requirements

• Children 6 months through 8 years of age who are receiving influenza vaccine for the first time or who have received only 1 dose before July 1 of the current year should receive 2 doses administered at least 4 weeks apart, ideally by the end of October 15, 17

Vaccine Selection and Administration

• Any age-appropriate influenza vaccine formulation can be used, including IIV or live attenuated influenza vaccine (LAIV) for healthy children 2 years and older without contraindications 17
• No preference exists for one product over another when multiple appropriate options are available 15, 17
• If the child received antiviral medication for treatment of the influenza infection, LAIV should not be administered until 48 hours after stopping the antiviral therapy 18, 16

Priority Populations

• Children with high-risk conditions should be prioritized for vaccination even after recent influenza infection, as they remain at elevated risk for complications from other circulating influenza strains 18, 17
• Their close contacts and caregivers should also be vaccinated to provide indirect protection 18, 17

Timing Optimization

• Ideally, vaccination should be completed by the end of October to ensure protection before peak influenza season, which typically occurs in January or later in 75% of seasons 18, 15
• However, vaccination should continue throughout the influenza season as long as viruses are circulating and unexpired vaccine is available 18

Routine Vaccination After Recent Influenza Infection in Babies

Key Decision Point: Illness Severity Assessment

• Minor illnesses with or without fever are NOT contraindications to vaccination, including mild upper respiratory symptoms, low-grade fever, or allergic rhinitis, according to the American Academy of Pediatrics 19, 20
• Moderate-to-severe febrile illness (high fever, active infection requiring hospitalization) requires deferral until clinical resolution, as recommended by the American Academy of Pediatrics 19, 20

Practical Application

• For babies recovering from influenza, if the baby appears well, is feeding normally, and has only minor residual symptoms (mild runny nose, occasional cough), proceed with routine vaccination immediately, as advised by the American Academy of Pediatrics 19
• If the baby still has high fever, appears systemically ill, or has significant respiratory distress, defer vaccination until recovery, according to the American Academy of Pediatrics 19, 20

Why This Matters for Morbidity and Mortality

• Babies, particularly those under 2 years, are at highest risk for severe influenza complications and hospitalization, highlighting the importance of timely vaccination, as noted by the American Academy of Pediatrics 21
• The American Academy of Pediatrics emphasizes that minor illnesses should not be barriers to timely immunization, to prevent vaccine-preventable diseases during peak respiratory illness season 19, 20